Related Experiment Videos
Leicester ECT trial: results in schizophrenia
The British Journal of Psychiatry : the Journal of Mental Science
|February 1, 1985
Summary
Real electroconvulsive therapy (ECT) significantly improved schizophrenia symptoms in a short-term trial. However, these benefits were not sustained at longer follow-up periods when treatment was not controlled.
Area of Science:
- Psychiatry
- Neurology
Background:
- Schizophrenia is a severe mental disorder.
- Electroconvulsive therapy (ECT) is a treatment option for severe mental disorders.
Purpose of the Study:
- To investigate the efficacy of real electroconvulsive therapy (ECT) compared to simulated ECT in patients with schizophrenia.
Main Methods:
- A double-blind trial was conducted with 19 patients meeting Present State Examination criteria for schizophrenia.
- Patients were randomly assigned to receive either eight real ECT or eight simulated ECT sessions.
- Neuroleptic medication was restricted during the four-week trial period.
Main Results:
- Patients receiving real ECT showed significantly greater improvement on the Montgomery-Asberg Schizophrenia Scale (MASS), a visual analogue global psychopathology scale, and a depression scale after four weeks.
- Improvements in MASS and global psychopathology were not attributed to reduced depressive symptoms.
- The superiority of real ECT was not evident at 12- and 28-week follow-ups when treatment was not controlled.
Conclusions:
- Real ECT demonstrates short-term efficacy in improving schizophrenia symptoms.
- The long-term benefits of real ECT for schizophrenia require further investigation, particularly in uncontrolled treatment settings.